reporting amino acids reporting amino acids the clinical
play

Reporting Amino Acids: Reporting Amino Acids: The Clinical - PowerPoint PPT Presentation

Reporting Amino Acids: Reporting Amino Acids: The Clinical Biochemist The Clinical Biochemist Dr J R Bonham, Sheffield Children s NHS Trust s NHS Trust Dr J R Bonham, Sheffield Children Why do we measure aminoacids aminoacids Why do


  1. Reporting Amino Acids: Reporting Amino Acids: The Clinical Biochemist The Clinical Biochemist Dr J R Bonham, Sheffield Children’ ’s NHS Trust s NHS Trust Dr J R Bonham, Sheffield Children

  2. Why do we measure aminoacids aminoacids Why do we measure in the laboratory? in the laboratory? • To detect inborn errors of metabolism • To detect inborn errors of metabolism • To monitor treatment • To monitor treatment – – PKU, MSUD, PKU, MSUD, argininaemia argininaemia, , ASA, OAT, citullinaemia citullinaemia, , cystinuria cystinuria, , tyrosinaemia tyrosinaemia, , ASA, OAT, homocystinuria homocystinuria • To assess nutritional wellbeing • To assess nutritional wellbeing – – TPN, artificial TPN, artificial diets diets • To identify renal tubular dysfunction • To identify renal tubular dysfunction • To investigate renal stones • To investigate renal stones • To add additional information when investigating • To add additional information when investigating hypoglycaemia (alanine alanine), ), hyperammonaemia hyperammonaemia hypoglycaemia ( (glutamine), lactic acidaemia acidaemia ( (alanine alanine) ) (glutamine), lactic

  3. Inborn errors of metabolism Inborn errors of metabolism detectable by aminoacid aminoacid analysis analysis detectable by Phenylketonuria* Phenylketonuria * Tyrosinaemia types I & II* Tyrosinaemia types I & II* Non ketototic ketototic Maple syrup urine disease Non Maple syrup urine disease hyperglycinaemia* * hyperglycinaemia Serine synthesis defects* Homocystinuria Serine synthesis defects* Homocystinuria Cystinuria* * Argininaemia* * Cystinuria Argininaemia Citrullinaemia* * OTC deficiency Citrullinaemia OTC deficiency Lysinuric protein intolerance* protein intolerance* Hypophosphatasia* * Lysinuric Hypophosphatasia ASA uria ASA uria* * OAT deficiency* OAT deficiency* Hartnup disease* disease* HHH syndrome* Hartnup HHH syndrome* Prolidase deficiency* deficiency* Sulphite oxidase oxidase deficiency deficiency Prolidase Sulphite *Cases detectable primarily by aminoacid analysis

  4. What kind of turnaround time What kind of turnaround time should we offer? should we offer? • Our own experience • Our own experience - - 50 quantitative aminoacid 50 quantitative aminoacid analyses coming to the lab in July analyses coming to the lab in July 2005 – – Mean turnaround 5.8d, SD 3.0d, range 1 Mean turnaround 5.8d, SD 3.0d, range 1- -15d 15d 2005 • Detection of • Detection of IEM IEM’ ’s s - 24h if urgent - 24h if urgent - 10d otherwise - 10d otherwise • To monitor treatment • To monitor treatment - 24h if urgent - 24h if urgent - 7d otherwise - 7d otherwise • General nutritional assessment • General nutritional assessment - 7d - 7d • Renal tubular function • Renal tubular function - - 7d 7d • Renal stones • Renal stones - 10d - 10d • As part of the investigation of • As part of the investigation of hyperammonaemia hyperammonaemia/ / hypoglycaemia/ lactic acidaemia acidaemia hypoglycaemia/ lactic - 7d - 7d

  5. Why is reporting so Why is reporting so important? important? • It answers a question posed by the • It answers a question posed by the requesting clinician requesting clinician • It acts as a permanent record as part of • It acts as a permanent record as part of the patients medical record the patients medical record • It can be used in future litigation • It can be used in future litigation • It is a serious potential cause of confusion • It is a serious potential cause of confusion • It is used to judge the quality of the • It is used to judge the quality of the service by users service by users

  6. What are the features of a What are the features of a good report? good report? • It is clear, easy to read and unambiguous • It is clear, easy to read and unambiguous • It separates fact from conjecture • It separates fact from conjecture ie ie findings from comment findings from comment • It contains all necessary information and • It contains all necessary information and NO unnecessary information NO unnecessary information • It should be suitable for the target • It should be suitable for the target audience audience • It answers the question and is clear about • It answers the question and is clear about the next steps if needed the next steps if needed • It is as short as possible • It is as short as possible

  7. How should we construct an How should we construct an aminoacid report? report? aminoacid • Method used • Method used - Quantitative or qualitative and very brief method - Quantitative or qualitative and very brief method type type - - Source of reference ranges Source of reference ranges • Findings • Findings - If qualitative any particular aminoacids aminoacids of note of note - If qualitative any particular - Quantitative results with units and age related - Quantitative results with units and age related reference range reference range • Comment • Comment - Clinically significant deviation from normal if any - Clinically significant deviation from normal if any - Any qualifying concerns eg eg dilute sample, dilute sample, - Any qualifying concerns evidence of sample deterioration or interference evidence of sample deterioration or interference

  8. How should we construct an How should we construct an aminoacid report? report? aminoacid • Conclusions • Conclusions No abnormalities detected No abnormalities detected - - - Nothing diagnostic or No significant abnormality - Nothing diagnostic or No significant abnormality - Results requiring further follow- -up up - Results requiring further follow - Possible disorder indicated with a brief - Possible disorder indicated with a brief differential diagnosis differential diagnosis • Advice for further investigations • Advice for further investigations Repeat or urine/plasma needed Repeat or urine/plasma needed - - - Other investigations required - Other investigations required - Advice about timescale - Advice about timescale • Need to test other family members • Need to test other family members • Note of whether the result has been • Note of whether the result has been telephoned telephoned

  9. Common problems Common problems • No sample obtained • No sample obtained • No clinical information provided • No clinical information provided • Correct test not requested • Correct test not requested eg eg urine urine homocystine homocystine to to exclude defects of homocystine homocystine metabolism metabolism exclude defects of • Poor sample provided • Poor sample provided eg eg too dilute, deterioration, too dilute, deterioration, drug interference drug interference • Inadequate analytical • Inadequate analytical reproduciblity reproduciblity eg eg phe phe • Unwillingness to commit to normal • Unwillingness to commit to normal • Lack of explanation about what the abnormal • Lack of explanation about what the abnormal results mean results mean • Lack of clarity about what to do next and when • Lack of clarity about what to do next and when • Lengthy reports with too many auto comments • Lengthy reports with too many auto comments • Results arrive too late • Results arrive too late • The wrong person or no • The wrong person or no- -one informed when one informed when telephone results are issued telephone results are issued

  10. What can we do? What can we do? • Ensure a regular dialogue with users, • Ensure a regular dialogue with users, lectures, newsletters, ward rounds and lectures, newsletters, ward rounds and telephone telephone • Ensure that the clinical question is clearly • Ensure that the clinical question is clearly stated and understood and that relevant stated and understood and that relevant clinical details are provided clinical details are provided • Ensure that we have clear written • Ensure that we have clear written standards for the service that are available standards for the service that are available (and used!) by staff and users eg eg clinical clinical (and used!) by staff and users details, sample labelling, turnaround time, details, sample labelling, turnaround time, reporting format, policy on dilute samples, reporting format, policy on dilute samples, follow- -ups etc ups etc follow • Audit regularly against these standards • Audit regularly against these standards

  11. What can we do? What can we do? • Conduct service evaluation by user • Conduct service evaluation by user questionnaire questionnaire • Evaluate whether the service makes a • Evaluate whether the service makes a difference difference • Modify the service and re • Modify the service and re- -audit at pre audit at pre- - planned intervals. Cost for 2000 samples pa workload. planned intervals. Cost for 2000 samples pa workload. Maybe equipment 20k, reagents & consumables 8k, staff time Maybe equipment 20k, reagents & consumables 8k, staff time 50k – – Total Total £ £78k pa 78k pa 50k • Compare practice with other similar centres in • Compare practice with other similar centres in UK and Europe UK and Europe • Explore alternative analytical approaches that • Explore alternative analytical approaches that may prove more clinically useful and more cost may prove more clinically useful and more cost effective effective

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend